Radar › Companies › Biopharma Outsourcing · New South Wales
Radar · Biopharma Outsourcing in New South Wales

Best Biopharma Outsourcing Companies in New South Wales, Australia

The 32 best Biopharma Outsourcing companies in New South Wales, Australia in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Biointelect.

32companies tracked
$33.6Mdisclosed funding
0unicorns
5have raised
FLIAR INTELLIGENCE · BIOPHARMA OUTSOURCING × NEW SOUTH WALES

Our analysis of 100 Biopharma Outsourcing companies

$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.

100companies analysed
68%cloud-native stacks
2025funding peak (by rounds)
2008median founding year
50median Fliar Index™
54kcombined LinkedIn audience
52%of audience held by top 3
2companies hiring publicly (12 mo)

Ranked: Best Biopharma Outsourcing companies in New South Wales

#CompanyDisclosed fundingLast roundStageFounderFoundedTech stackRecent signals
1Biointelect
Market evaluation and strategy design for biopharma, medical device and IVD companies
$33M15 mo agoFunding Raised—2011WordPressMySQLSalesforce+27—
2Smart MCs
Smart biomaterials and microfluidic solutions provider for bioproduction
$600K42 mo agoFunding RaisedLin Ding
Co-Founder & CTO
2022——
3Lipa
Contract manufacturer of dietary supplements and OTC pharmaceutical products
$144K86 mo agoFunding Raised—1995WordPress Block EditorWordPressMySQL+18—
4Formative Health
Consulting services to biopharma and biotech industries
—121 mo agoSeries ANeil Formica
CEO & Director
2012——
5Paratus Clinical
Provider of clinical trial related services
—133 mo agoSeedJeff Wall
Co-Founder
2013Animate.cssMaterial Design LiteBootstrap+14—
6AccessSync
Provider of marketing access solutions for biopharma companies
——Unfunded—2018WordPress Block EditorWordPressMySQL+32—
7Brandwood CKC
Provider of regulatory, quality systems and consultancy services
——Unfunded—2000——
8Cpharm
Provider of medical information, review, marketing, and other services
——Unfunded—2009——

Top 5 Biopharma Outsourcing companies in New South Wales

#1
Funding Raised · Brookvale, New South Wales · founded 2011 · 26 employees
$32.9Mraised
▾

Biointelect offers market evaluation and strategy design and development services for biopharmaceutical, medical device, and IVD companies. While for early stage companies they provide product development support through their commercial and market insights, for late stage companies they offer services for product planning, project startup and development and also in identifying the right commercial partners. Base on their expertise in market evaluation, they help clients in designing their clinical, regulatory, reimbursement and market-entry strategies.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 5k LinkedIn followers — 9.8% of this cohort's audience
Hiring: 1 hiring post in 12 mo (public) · hiring: Administrative Assistant
Funding rounds
  • Jul 2025Grant (prize money)$32.9M
Investors
The Australian health system
Tech stack
Apache Http ServerCore-JsElementorFont AwesomeGoogle AnalyticsGoogle Font Api
#2
Funding Raised · Ultimo, New South Wales · founded 2022 · 2 employees
$600Kraised
▾

Smart biomaterials and microfluidic solutions provider for bioproduction. They specialize in creating customized biomaterials and microfluidic solutions tailored to specific cell types and applications. Their product suite includes microcarriers for efficient cell culture, hydrogels for tissue modeling and wound healing, and microfluidic platforms for various applications like cell sorting and droplet generation. These solutions are designed to streamline research and production processes in sectors such as stem cell therapeutics and cultivated meat production, aiming to improve efficiency and reduce waste. The company supports researchers and industry partners in scaling up cell production.

Funding rounds
  • Apr 2023Grant (prize money)$600K
Founders & team
Lin DingCo-Founder & CTOPayar RadfarCo-Founder & CEO
Investors
business.gov.au
#3
Funding Raised · Minto, New South Wales · founded 1995 · 300 employees
$144.4Kraised
▾

Contract manufacturer of dietary supplements and OTC pharmaceutical products

LinkedIn Pulse recent public activity · Jul 2026
Audience: 10k LinkedIn followers — 18.6% of this cohort's audience
Activity: 1 product launches · 1 awards announced in 12 mo
Funding rounds
  • Aug 2019Grant (prize money)$118.9K
  • Jun 2014Grant (prize money)$25.4K
Investors
Europa
Tech stack
Apache Http ServerCloudflareFastlyGoogle Font ApiGoogle Tag ManagerGravity Forms
#4
Series A · Cudgen, New South Wales · founded 2012
—raised
▾

Formative Health offers consulting services to biopharma and biotech industries. They offer consulting services for medical affairs, clinical development strategy and plan development, business strategy, and public health and training.

Funding rounds
  • Sep 2016Series A—
Founders & team
Neil FormicaCEO & Director
Investors
Pamplona Capital Management
#5
Seed · Sydney, New South Wales · founded 2013 · 75 employees
—raised
▾

Paratus Clinical provides services in Australia and New Zealand particularly for early Phase and late Phase (in Primary care) Clinical Research. It provides clinical trial related services to pharmaceutical companies, contract research organisations (CROs), biotechnology companies, medical device companies and clinical sites. It is focused in the recruitment and conduct of clinical trials. Also provides biostatistics services, data management services and clinical research consulting services.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 3k LinkedIn followers — 5.7% of this cohort's audience
Activity: 2 partnerships (incl. ARCS Australia) announced in 12 mo
Funding rounds
  • Sep 2015Seed—
Founders & team
Jeff WallCo-Founder
Investors
Carthona Capital, Cthulhu Ventures
Tech stack
Animate.CssBootstrapCore-JsFacebook PixelFont AwesomeGoogle Analytics

Funding & investor landscape

$33.6Mtotal disclosed funding
3companies funded
4disclosed rounds
0rounds last 90 days
Most active investors
Carthona Capital1 rounds
Cicada Innovations1 rounds
Cthulhu Ventures1 rounds
Europa1 rounds
Pamplona Capital Management1 rounds
Quadrant Private Equity1 rounds
Sandbar Investments1 rounds
The Australian health system1 rounds
business.gov.au1 rounds

Notable founders

Lin Ding
Co-Founder & CTO · Smart MCs
Payar Radfar
Co-Founder & CEO · Smart MCs
Neil Formica
CEO & Director · Formative Health
Jeff Wall
Co-Founder · Paratus Clinical
Prism market signals · Australia · country-scoped Prism corpus, 115,584 docs

Market landscape — 10 sub-themes by coverage

Share of Biopharma Outsourcing coverage by sub-theme.

Regulatory-risk over time flat

Funding & growth over time

funding rising · growth rising

RESEARCH SIGNALS · Australia

How research on Biotechnology is moving in Australia

A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 861 Australia-affiliated papers.

research sentiment over time
200820162026
enthusiastic · positive · guarded tone
Tone is overwhelmingly optimistic and intensifying — the enthusiastic (strongly-positive) share moved 31% → 45% across 2008–2026.
top research entities
  • University College London67
  • The University of Queensland63
  • The University of Melbourne59
  • Agriculture and Food54
  • La Trobe University35
leading researchers
Joanne E. Davis · Pratyush Mishra · Annelie Marquardt · Philippe Moncuquet · Katrina J. Broughton · Robert E. Sharwood · Warren C. Conaty · Vikas Kumar
▲ Breakthroughs189 · 22%
▲ 21%→23% share
▲1.1× share momentum0 median citations81% since 2021mostly methods-led
Breakthroughs are rising (21%→23% of field), led by Mutant.
rising sub-themes (early→recent)
  • Mutant2→11
  • Genome1→7
  • Immune system1→5
  • Antibody1→4
  • Mitochondrion2→4
Newly emergingGene 0→16 · Mutation 0→9 · Biosensor 0→8
Landmark Shifting the limits in wheat research and breeding using a fully annotated reference genome · 3,312 cites
◆ Advancements307 · 36%
▲ 32%→37% share
▲1.2× share momentum0 median citations82% since 2021mostly empirical
Advancements are rising (32%→37% of field), led by Gene.
rising sub-themes (early→recent)
  • Gene5→17
  • Immune system2→13
  • Antibody1→10
  • Messenger RNA1→10
  • Mutant1→9
Newly emergingAgriculture 0→12 · Sustainability 0→10 · Microbiome 0→8
Landmark Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice · 1,441 cites
▼ Concerns214 · 25%
▼ 35%→21% share
▼0.6× share momentum0 median citations68% since 2021mostly reviews
Concerns are cooling (35%→21% of field), led by Agriculture.
rising sub-themes (early→recent)
  • Agriculture5→19
  • Sustainability3→8
  • Emerging technologies1→4
  • Resistance (ecology)3→6
  • Bacteria2→5
Newly emergingHuman health 0→8 · Integrated pest management 0→5 · Cell 0→5
Landmark Breeding Technologies to Increase Crop Production in a Changing World · 2,290 cites
RESEARCH HOTSPOTS · Australia

Where biotechnology is researched across Australia

Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.

Melbourne169 · +0.27
Hot · Cell cultureAdvancing · MicrobiomeOpportunity · StainingConcern · Health benefits
Brisbane111 · +0.33
Hot · Synthetic biologyAdvancing · In vivoOpportunity · Resistance (ecology)Concern · Food security
Sydney99 · +0.36
Hot · Table (database)Advancing · MetagenomicsOpportunity · TranscriptomeConcern · Agriculture
Perth49 · +0.30
Hot · CropAdvancing · GenomeOpportunity · Antioxidant
Adelaide46 · +0.27
Hot · GermplasmAdvancing · AgronomyOpportunity · Antibody
Canberra25 · +0.12
Hot · Antibiotic resistanceOpportunity · GeneConcern · Microbiology

Common questions

How many Biopharma Outsourcing companies are there in New South Wales, Australia?
Radar tracks 32 indexable Biopharma Outsourcing companies headquartered in New South Wales, Australia that meet our profile-completeness bar.
What is the total funding raised by Biopharma Outsourcing companies in New South Wales, Australia?
The Biopharma Outsourcing companies in New South Wales, Australia on this list have raised a combined $33.6M in disclosed equity funding across 3 funded companies.
Which is the highest-funded Biopharma Outsourcing company in New South Wales, Australia?
Biointelect is the highest-funded Biopharma Outsourcing company in New South Wales, Australia, with $32.9M in disclosed equity funding.
How many Biopharma Outsourcing companies in New South Wales, Australia are funded?
3 of the 32 Biopharma Outsourcing companies in New South Wales, Australia on this list have disclosed at least one equity funding round.
How many Biopharma Outsourcing unicorns are there in New South Wales, Australia?
None of the Biopharma Outsourcing companies in New South Wales, Australia on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in New South Wales, Australia Biopharma Outsourcing companies?
The most active investors in New South Wales, Australia Biopharma Outsourcing companies on this list include Carthona Capital, Cicada Innovations, Cthulhu Ventures, Europa, Pamplona Capital Management.
Rohit KhannaTrends & Stories

Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.

Coming soon